ArticleClinical hypertension2024
Elevated triglyceride-glucose index is a risk factor for progression to prehypertension in normoglycemic Japanese: a 5-year retrospective cohort study.
Article in Clinical hypertension, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Disease risk perception, health intervention intention and their influencing factors among prehypertensive and hypertensive populations: a cross-sectional study with 1050 participants.BMC public health · 2026Article
- Association of the combined triglyceride glucose-body mass index and serum IQGAP3 in appraising coronary lesion severity in type 2 diabetes.Frontiers in endocrinology · 2026Article
- Association of the triglyceride-glucose series indices with hypertension and pre-hypertension in Anhui China.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe triglyceride-glucose (TyG) index is an alternative biomarker of insulin resistance that may be associated with elevated blood pressure. However, the relationship between the TyG index and the risk of prehypertension remains unclear. This longitudinal, retrospective cohort study aimed to investigate the connection between the TyG index and the risk among Japanese population.
methodsWe enrolled 17,758 participants who underwent medical health checkups in 2017 (baseline) and 2022. At baseline, all participants were normotensive and normoglycemic state, and none were using triglyceride-lowering medications. Participants were divided into four groups according to quartiles of the TyG index at baseline. The risk of progressing to prehypertension was evaluated using multivariable Cox proportional hazard models. In addition, multivariate restricted cubic spline analysis was conducted to examine the dose-response relationship. Furthermore, receiver operating characteristic (ROC) curve analysis was performed to determine the predictive value of the TyG index for progression to prehypertension.
resultsCompared with the lowest quartile (Q1) of the TyG index group, the adjusted hazard ratios (95% confidence intervals) for progression to prehypertension in the Q2, Q3, and Q4 groups were 1.05 (0.95-1.19), 1.14 (1.02-1.30), and 1.28 (1.11-1.50), respectively. The restricted cubic spline analysis demonstrated a dose-response relationship between the TyG index and the risk of prehypertension. The area under the ROC curve was 0.60 (0.59-0.61), demonstrating a sensitivity of 56.2% and specificity of 58.8%.
conclusionsThe findings suggest that an elevated TyG index may be independently and positively associated with an increased risk of progression to prehypertension in the Japanese population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.